{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:30:45Z","timestamp":1790393445567,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":7609,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1017\/s1041610204000079","type":"journal-article","created":{"date-parts":[[2004,4,2]],"date-time":"2004-04-02T09:30:43Z","timestamp":1080898243000},"page":"61-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Behavioral symptoms and the administration of psychotropic drugs to aged patients with dementia in nursing homes and in acute geriatric wards"],"prefix":"10.1016","volume":"16","author":[{"given":"K.H.","family":"Pitkala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.V.","family":"Laurila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.E.","family":"Strandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.S.","family":"Tilvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610204000079_bb0005","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1176\/ajp.153.2.243","article-title":"Relationship of aggressive behavior to other neuropsychiatric symptoms in patients with Alzheimer's disease","volume":"153","author":"Aarsland","year":"1996","journal-title":"American Journal of Psychiatry"},{"key":"10.1017\/S1041610204000079_bb0010","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1017\/S1041610204000079_bb0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM198901263200406","article-title":"Use of psychoactive medications and the quality of care in rest homes","volume":"320","author":"Avorn","year":"1989","journal-title":"New England Journal of Medicine"},{"key":"10.1017\/S1041610204000079_bb0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2165\/00002512-200016060-00005","article-title":"Risperidone: a review of its use in the management of the behavioural and psychological symptoms of dementia","volume":"16","author":"Bhana","year":"2000","journal-title":"Drugs and Aging"},{"key":"10.1017\/S1041610204000079_bb0025","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bmj.324.7337.606","article-title":"Validating scales and indexes","volume":"324","author":"Bland","year":"2002","journal-title":"British Medical Journal"},{"key":"10.1017\/S1041610204000079_bb0030","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/gps.382","article-title":"Psychosis, depression and behavioural disturbances in Sydney nursing home residents: prevalence and predictors","volume":"16","author":"Brodaty","year":"2001","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610204000079_bb0035","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1212\/WNL.48.5_Suppl_6.17S","article-title":"Clinical features and pharmalogic treatment of behavioral symptoms of Alzheimer's disease","volume":"48","author":"Borson","year":"1997","journal-title":"Neurology"},{"key":"10.1017\/S1041610204000079_bb0040","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1192\/bjp.157.1.72","article-title":"Psychiatric phenomena in Alzheimer's disease. I: Disorders of thought content","volume":"157","author":"Burns","year":"1990","journal-title":"British Journal of Psychiatry"},{"key":"10.1017\/S1041610204000079_bb0045","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1192\/bjp.157.1.86","article-title":"Psychiatric phenomena in Alzheimer's disease. IV: Disorders of behaviour","volume":"157","author":"Burns","year":"1990","journal-title":"British Journal of Psychiatry"},{"key":"10.1017\/S1041610204000079_bb0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1192\/bjp.157.1.81","article-title":"Psychiatric phenomena in Alzheimer's disease. III: Disorders of mood","volume":"157","author":"Burns","year":"1990","journal-title":"British Journal of Psychiatry"},{"key":"10.1017\/S1041610204000079_bb0055","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1192\/bjp.157.1.76","article-title":"Psychiatric phenomena in Alzheimer's disease. II: Disorders of perception","volume":"157","author":"Burns","year":"1990","journal-title":"British Journal of Psychiatry"},{"key":"10.1017\/S1041610204000079_bb0060","doi-asserted-by":"crossref","first-page":"M255","DOI":"10.1093\/geronj\/48.6.M255","article-title":"Psychopathology associated with Alzheimer's disease and related disorders","volume":"48","author":"Cohen","year":"1993","journal-title":"Journal of Gerontology, Medical Sciences"},{"key":"10.1017\/S1041610204000079_bb0065","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1017\/S1041610299005797","article-title":"Psychotropic drug utilization in long-term-care facilities for the elderly in Ontario, Canada","volume":"11","author":"Conn","year":"1999","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610204000079_bb0070","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1212\/WNL.53.5.946","article-title":"A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia","volume":"53","author":"De Deyn","year":"1999","journal-title":"Neurology"},{"issue":"Suppl 2","key":"10.1017\/S1041610204000079_bb0075","first-page":"S3","article-title":"The interrelations between psychosis, behavioral disturbance, and depression in Alzheimer's disease","volume":"13","author":"Devanand","year":"1999","journal-title":"Alzheimer Diseases and Associated Disorders"},{"key":"10.1017\/S1041610204000079_bb0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/archpsyc.1997.01830150083012","article-title":"The course of psychopathologic features in mild to moderate Alzheimer's disease","volume":"54","author":"Devanand","year":"1997","journal-title":"Archives of General Psychiatry"},{"key":"10.1017\/S1041610204000079_bb0085","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1176\/ajp.155.11.1512","article-title":"A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease","volume":"155","author":"Devanand","year":"1998","journal-title":"American Journal of Psychiatry"},{"key":"10.1017\/S1041610204000079_bb0090","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1017\/S1041610201007505","article-title":"Use of psychotropics in Sydney nursing homes: associations with depression, psychosis, and behavioral disturbances","volume":"13","author":"Draper","year":"2001","journal-title":"International Psychogeriatrics"},{"issue":"Suppl 4","key":"10.1017\/S1041610204000079_bb0095","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/00004850-199709004-00005","article-title":"Managing the behavioral and psychological signs and symptoms of dementia","author":"Finkel","year":"1997","journal-title":"International Clinical Psychopharmacology, (Sept 12)"},{"key":"10.1017\/S1041610204000079_bb0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"Journal of Psychiatric Research"},{"key":"10.1017\/S1041610204000079_bb0105","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/ageing\/25.5.405","article-title":"Review: delusions in dementia","volume":"25","author":"Harvey","year":"1996","journal-title":"Age and Ageing"},{"key":"10.1017\/S1041610204000079_bb0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1192\/bjp.174.1.39","article-title":"Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease. A longitudinal study","volume":"174","author":"Hope","year":"1999","journal-title":"British Journal of Psychiatry"},{"key":"10.1017\/S1041610204000079_bb0115","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"British Journal of Psychiatry"},{"key":"10.1017\/S1041610204000079_bb0120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4088\/JCP.v60n0207","article-title":"Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group","volume":"60","author":"Katz","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610204000079_bb0125","series-title":"Cochrane Library, Issue 1, 2002","article-title":"Thioridazine for dementia (Cochrane Review)","author":"Kirchner","year":"2002"},{"key":"10.1017\/S1041610204000079_bb0130","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1532-5415.1992.tb01847.x","article-title":"Delusions and behavioral disturbances in cognitively impaired elderly persons","volume":"40","author":"Lachs","year":"1992","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1017\/S1041610204000079_bb0135","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4088\/JCP.v59n1010","article-title":"Efficacy and safety of neuroleptics in behavioral disorders associated with dementia","volume":"59","author":"Lanctot","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610204000079_bb0140","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1176\/ps.47.9.951","article-title":"A ten-year review on the effect of OBRA-87 on psychotropic prescribing practices in an academic nursing home","volume":"47","author":"Lantz","year":"1996","journal-title":"Psychiatric Services"},{"key":"10.1017\/S1041610204000079_bb0145","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1532-5415.1998.tb02540.x","article-title":"Newer psychotropic medication use in nursing home residents","volume":"46","author":"Lasser","year":"1998","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1017\/S1041610204000079_bb0150","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000071004","article-title":"The impact of different diagnostic criteria on prevalence rates of delirium","volume":"16","author":"Laurila","year":"2003","journal-title":"Dementia and Cognitive Disorders"},{"key":"10.1017\/S1041610204000079_bb0155","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1532-5415.1999.tb01898.x","article-title":"Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs","volume":"47","author":"Leiptzig","year":"1999","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1017\/S1041610204000079_bb0160","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1176\/ajp.153.11.1438","article-title":"Longitudinal assessment of symptoms depression, agitation, and psychosis in 181 patients with Alzheimer's disease","volume":"153","author":"Levy","year":"1996","journal-title":"American Journal of Psychiatry"},{"key":"10.1017\/S1041610204000079_bb0165","series-title":"Cochrane Library, Issue 1, 2002","article-title":"Haloperidol for agitation in dementia (Cochrane Review)","author":"Lonergan","year":"2002"},{"key":"10.1017\/S1041610204000079_bb0170","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/gps.448","article-title":"Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study","volume":"16","author":"Lyketsos","year":"2001","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610204000079_bb0175","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/1099-1166(200101)16:1<39::AID-GPS269>3.0.CO;2-F","article-title":"Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments","volume":"16","author":"Margallo-Lana","year":"2001","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610204000079_bb0180","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/bmj.323.7310.410","article-title":"The challenge of looking after people with dementia","volume":"323","author":"Marshall","year":"2001","journal-title":"British Medical Journal"},{"key":"10.1017\/S1041610204000079_bb0185","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/bmj.312.7031.611","article-title":"Survey of neuroleptic prescribing in residents of nursing homes in Glasgow","volume":"312","author":"McGrath","year":"1996","journal-title":"British Medical Journal"},{"key":"10.1017\/S1041610204000079_bb0190","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(00)03399-7","article-title":"Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study","volume":"356","author":"McKeith","year":"2000","journal-title":"Lancet"},{"key":"10.1017\/S1041610204000079_bb0195","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1212\/WNL.46.1.130","article-title":"The spectrum of behavioral changes in Alzheimer's disease","volume":"46","author":"Mega","year":"1996","journal-title":"Neurology"},{"key":"10.1017\/S1041610204000079_bb0200","series-title":"Finne-Soveri, H, Bjorkgren, M., et al. (2001). Implementation of RAI-database and benchmarking of long-term care. RAI report 1\/2000. (In Finnish)","author":"Noro","year":"2001"},{"key":"10.1017\/S1041610204000079_bb0205","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1600-0447.1992.tb03242.x","article-title":"A controlled multicenter study of citalopram and placebo in elderly depressed patients with and without concomitant dementia","volume":"86","author":"Nyth","year":"1992","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1017\/S1041610204000079_bb0210","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1532-5415.2003.51057.x","article-title":"The incremental effect of dementia-related problem behaviors on the time to nursing home placement in poor, frail, demented older people","volume":"51","author":"Phillips","year":"2003","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1017\/S1041610204000079_bb0215","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1176\/appi.ajp.159.3.460","article-title":"Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients","volume":"159","author":"Pollock","year":"2002","journal-title":"American Journal of Psychiatry"},{"key":"10.1017\/S1041610204000079_bb0220","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4088\/JCP.v62n0506","article-title":"Rapid onset of therapeutic effect of risperidone versus haloperidol in a double-blind randomized trial","volume":"62","author":"Rabinowitz","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610204000079_bb0225","first-page":"S9","article-title":"Behavioral symptoms in Alzheimer's disease: phenomenology and treatment","volume":"48","author":"Reisberg","year":"1987","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610204000079_bb0230","first-page":"S20","article-title":"The efficacy of cholinesterase inhibitors in treating the behavioral symptoms of dementia","volume":"127","author":"Rosier","year":"2002","journal-title":"International Journal of Clinical Practice"},{"key":"10.1017\/S1041610204000079_bb0235","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s002280100348","article-title":"Psychotropic drug use in nursing home -diagnostic indications and variations between institutions","volume":"57","author":"Ruths","year":"2001","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1017\/S1041610204000079_bb0240","series-title":"Clinical Epidemiology. A Basic Science for Clinical Medicine","author":"Sackett","year":"1991"},{"key":"10.1017\/S1041610204000079_bb0245","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1532-5415.1999.tb01297.x","article-title":"Validity and responsiveness of the Minimum Data Set","volume":"47","author":"Snowden","year":"1999","journal-title":"Journal of the American Geriatric Society"},{"key":"10.1017\/S1041610204000079_bb0250","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5694\/j.1326-5377.1999.tb127781.x","article-title":"A follow-up survey of psychotropic drug use in Sydney nursing homes","volume":"170","author":"Snowdon","year":"1999","journal-title":"Medical Journal of Australia"},{"key":"10.1017\/S1041610204000079_bb0255","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S1041610201007578","article-title":"Agitation in demented patients in an acute care hospital: prevalence, disruptiveness, and staff burden","volume":"13","author":"Sourial","year":"2001","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610204000079_bb0260","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1212\/WNL.44.12.2300","article-title":"Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease; prospective analyses from the Predictors Study","volume":"44","author":"Stern","year":"1994","journal-title":"Neurology"},{"key":"10.1017\/S1041610204000079_bb0265","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/archpsyc.57.10.968","article-title":"Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities","volume":"57","author":"Street","year":"2000","journal-title":"Archives of General Psychiatry"},{"key":"10.1017\/S1041610204000079_bb0270","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1002\/1099-1166(200112)16:1+<::AID-GPS569>3.0.CO;2-J","article-title":"Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer's disease","volume":"16","author":"Street","year":"2001","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610204000079_bb0275","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1212\/WNL.54.12.2269","article-title":"A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group","volume":"54","author":"Tariot","year":"2000","journal-title":"Neurology"},{"key":"10.1017\/S1041610204000079_bb0280","first-page":"M49","article-title":"Cognitive decline in Alzheimer's disease: a longitudinal investigation of risk factors for accelerated decline","volume":"50A","author":"Teri","year":"1995","journal-title":"Journal Of Gerontology: Medical Sciences"},{"key":"10.1017\/S1041610204000079_bb0285","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1176\/ajp.146.5.577","article-title":"Overview of depression and psychosis in Alzheimer's disease","volume":"146","author":"Wragg","year":"1989","journal-title":"American Journal of Psychiatry"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224045307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224045307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610204000079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T16:06:52Z","timestamp":1736352412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224045307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S1041610224045307"],"URL":"https:\/\/doi.org\/10.1017\/s1041610204000079","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behavioral symptoms and the administration of psychotropic drugs to aged patients with dementia in nursing homes and in acute geriatric wards","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610204000079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}